24 related articles for article (PubMed ID: 9485191)
1. CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.
Gaspari AA; Burns R; Nasir A; Ramirez D; Barth RK; Haidaris CG
Infect Immun; 1998 Sep; 66(9):4440-9. PubMed ID: 9712799
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.
Hutchings A; Purcell WM; Benfield MR
Clin Exp Immunol; 1999 Nov; 118(2):247-52. PubMed ID: 10540186
[TBL] [Abstract][Full Text] [Related]
3. Regulation of key molecules of immunological synapse by T11TS immunotherapy abrogates Cryptococcus neoformans infection in rats.
Sk Md OF; Hazra I; Datta A; Mondal S; Moitra S; Chaudhuri S; Das PK; Basu AK; Mishra R; Chaudhuri S
Mol Immunol; 2020 May; 122():207-221. PubMed ID: 32388483
[TBL] [Abstract][Full Text] [Related]
4. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.
Teitelbaum R; Glatman-Freedman A; Chen B; Robbins JB; Unanue E; Casadevall A; Bloom BR
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15688-93. PubMed ID: 9861031
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
6. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
[TBL] [Abstract][Full Text] [Related]
7. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans.
Monari C; Kozel TR; Casadevall A; Pietrella D; Palazzetti B; Vecchiarelli A
Immunology; 1999 Sep; 98(1):27-35. PubMed ID: 10469230
[TBL] [Abstract][Full Text] [Related]
8. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans.
Pietrella D; Perito S; Bistoni F; Vecchiarelli A
Infect Immun; 2001 Mar; 69(3):1508-14. PubMed ID: 11179320
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes.
Vecchiarelli A; Monari C; Retini C; Pietrella D; Palazzetti B; Pitzurra L; Casadevall A
Eur J Immunol; 1998 Jan; 28(1):114-21. PubMed ID: 9485191
[TBL] [Abstract][Full Text] [Related]
11. From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.
Chaperot L; Jacob MC; Molens JP; Manches O; Bensa JC; Plumas J
Leuk Lymphoma; 2000 Jul; 38(3-4):247-63. PubMed ID: 10830732
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
Levitz SM; Specht CA
FEMS Yeast Res; 2006 Jun; 6(4):513-24. PubMed ID: 16696647
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
